Author
Kejin Hu
Other affiliations: Cornell University, University of Pittsburgh, University of Hong Kong ...read more
Bio: Kejin Hu is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Reprogramming & Induced pluripotent stem cell. The author has an hindex of 15, co-authored 31 publications receiving 3129 citations. Previous affiliations of Kejin Hu include Cornell University & University of Pittsburgh.
Papers
More filters
TL;DR: Results demonstrate that reprograming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.
Abstract: Reprogramming differentiated human cells to induced pluripotent stem (iPS) cells has applications in basic biology, drug development, and transplantation. Human iPS cell derivation previously required vectors that integrate into the genome, which can create mutations and limit the utility of the cells in both research and clinical applications. We describe the derivation of human iPS cells with the use of nonintegrating episomal vectors. After removal of the episome, iPS cells completely free of vector and transgene sequences are derived that are similar to human embryonic stem (ES) cells in proliferative and developmental potential. These results demonstrate that reprogramming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.
2,425 citations
TL;DR: It is demonstrated that iPSCs free of transgene and vector sequences could be generated from human BM and CB mononuclear cells using non-integrating episomal vectors and showed a unique complex chromosomal translocation identified in marrow sample while displaying typical embryonic stem cell phenotype and pluripotent differentiation potential.
261 citations
TL;DR: This survey presents overviews of iPSC technologies with the intention to provide a quick yet comprehensive reference for both new and experienced reprogrammers.
Abstract: Generation of induced pluripotent stem cells (iPSCs) via the ectopic expression of reprogramming factors is a simple, advanced, yet often perplexing technology due to low efficiency, slow kinetics, and the use of numerous distinct systems for factor delivery. Scientists have used almost all available approaches for the delivery of reprogramming factors. Even the well-established retroviral vectors confuse some scientists due to different tropisms in use. The canonical virus-based reprogramming poses many problems, including insertional mutagenesis, residual expression and re-activation of reprogramming factors, uncontrolled silencing of transgenes, apoptosis, cell senescence, and strong immunogenicity. To eliminate or alleviate these problems, scientists have tried various other approaches for factor delivery and transgene removal. These include transient transfection, nonintegrating viral vectors, Cre-loxP excision of transgenes, excisable transposon, protein transduction, RNA transfection, microRNA transfection, RNA virion, RNA replicon, nonintegrating replicating episomal plasmids, minicircles, polycistron, and preintegration of inducible reprogramming factors. These alternative approaches have their own limitations. Even iPSCs generated with RNA approaches should be screened for possible transgene insertions mediated by active endogenous retroviruses in the human genome. Even experienced researchers may encounter difficulty in selecting and using these different technologies. This survey presents overviews of iPSC technologies with the intention to provide a quick yet comprehensive reference for both new and experienced reprogrammers.
89 citations
TL;DR: CatL is transcribed in one type of cell, and the very cell evolves quickly to a morphologically different cell where the enzyme functions, which supports the previous suggestion that F-cell is the precursor of B-cell.
Abstract: Cathepsin L (CatL) has been readily localized in the large vacuole and in the apical complex of the digestive B-cell of the shrimp hepatopancreas. Immunogold technique revealed the occurrence of CatL in zymogen granule, digestive body and digestive vacuole of the B-cell in the hepatopancreas of Metapenaeus ensis. Coalescences of zymogen granule with sub-apical vacuole, and of two small digestive bodies were observed. This progressive coalescence of CatL vesicles is direct evidence of involvement of CatL in intracellular digestion. Released CatL vesicles and free CatL were found in the lumen of hepatopancreatic tubule. CatL mRNA existed in F-cell, but not in the mature B-cell. This finding supports the previous suggestion that F-cell is the precursor of B-cell. F-cell is a transient form. Transition from F-cell to B-cell is fast. We define F-cell as the transcribing cell, F/B-cell as the enzyme-synthesizing cell and B-cell as the enzyme-secreting cell. For the first time, we suggest that R-cell is the replacing cell for the leaving B-cell. CatL degrades nutrient intracellularly and extracellularly. The most interesting finding is that CatL is transcribed in one type of cell, and the very cell evolves quickly to a morphologically different cell where the enzyme functions.
81 citations
TL;DR: In this article, the authors found that chitosan was extractable from all the 33 fungal strains from the four classes of Zygomycetes and found that high level of chitosity was extracted from some non-zygomycete strains.
71 citations
Cited by
More filters
28 Jul 2005
TL;DR: PfPMP1）与感染红细胞、树突状组胞以及胎盘的单个或多个受体作用，在黏附及免疫逃避中起关键的作�ly.
Abstract: 抗原变异可使得多种致病微生物易于逃避宿主免疫应答。表达在感染红细胞表面的恶性疟原虫红细胞表面蛋白1（PfPMP1）与感染红细胞、内皮细胞、树突状细胞以及胎盘的单个或多个受体作用，在黏附及免疫逃避中起关键的作用。每个单倍体基因组var基因家族编码约60种成员，通过启动转录不同的var基因变异体为抗原变异提供了分子基础。
18,940 citations
01 Aug 2000
TL;DR: Assessment of medical technology in the context of commercialization with Bioentrepreneur course, which addresses many issues unique to biomedical products.
Abstract: BIOE 402. Medical Technology Assessment. 2 or 3 hours. Bioentrepreneur course. Assessment of medical technology in the context of commercialization. Objectives, competition, market share, funding, pricing, manufacturing, growth, and intellectual property; many issues unique to biomedical products. Course Information: 2 undergraduate hours. 3 graduate hours. Prerequisite(s): Junior standing or above and consent of the instructor.
4,833 citations
TL;DR: It is shown that this approach can reprogram multiple human cell types to pluripotency with efficiencies that greatly surpass established protocols and represents a safe, efficient strategy for somatic cell reprogramming and directing cell fate that has broad applicability for basic research, disease modeling, and regenerative medicine.
2,627 citations
TL;DR: Document S1.
1,890 citations
TL;DR: It is confirmed that beating cardiomyocytes Differentiated from piPSCs results in cells that secrete ATP, a substance that can be converted into ATP by the immune system through cell reprograming.
1,806 citations